JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.04% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.55% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Impinj
PI
$5.28B
| $1.47M | ﹤0.01% |
24,991
-23,394
| -48% | -$1.18M |
|
3627
PUT
Progressive
PGR
$122B
| $1.47M | ﹤0.01% |
+12,600
| New | +$1.43M |
|
|
TPC
3628
Tutor Perini Cor
TPC
$5.09B
| $1.47M | ﹤0.01% |
166,857
-97,305
| -37% | -$940K |
|
3629
Instil Bio
TIL
$50.1M
| $1.46M | ﹤0.01% |
15,829
-126
| -0.8% | -$17.8K |
|
|
INST
3630
DELISTED
Instructure Holdings, Inc.
INST
| $1.46M | ﹤0.01% |
64,325
+58,627
| +1,029% | +$1.11M |
|
|
WSR
3631
DELISTED
Whitestone REIT
WSR
| $1.46M | ﹤0.01% |
135,678
+80,982
| +148% | +$973K |
|
|
AFTR
3632
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
| $1.46M | ﹤0.01% |
149,900
-199,100
| -57% | -$1.93M |
|
|
DALS
3633
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $1.45M | ﹤0.01% |
150,000
| – | – |
|
|
BSAQ
3634
DELISTED
Black Spade Acquisition Co
BSAQ
| $1.45M | ﹤0.01% |
149,926
-296,467
| -66% | -$2.87M |
|
3635
Northwest Bancshares
NWBI
$2.31B
| $1.45M | ﹤0.01% |
113,419
-83,020
| -42% | -$1.06M |
|
3636
Precision BioSciences
DTIL
$205M
| $1.45M | ﹤0.01% |
30,221
+9
| +0% | +$528 |
|
3637
CALL
Acadia Pharmaceuticals
ACAD
$4.87B
| $1.45M | ﹤0.01% |
+102,700
| New | +$1.92M |
|
3638
iShares MSCI Intl Value Factor ETF
IVLU
$4.55B
| $1.45M | ﹤0.01% |
65,252
-21,259
| -25% | -$514K |
|
3639
Clean Energy Fuels
CLNE
$403M
| $1.44M | ﹤0.01% |
322,081
-84,207
| -21% | -$487K |
|
3640
Telos
TLS
$339M
| $1.44M | ﹤0.01% |
178,357
+34,432
| +24% | +$297K |
|
3641
Phathom Pharmaceuticals
PHAT
$775M
| $1.44M | ﹤0.01% |
170,787
-4,775
| -3% | -$49.1K |
|
3642
Planet Labs
PL
$8.8B
| $1.44M | ﹤0.01% |
332,188
+307,381
| +1,239% | +$1.59M |
|
3643
The RealReal
REAL
$1.39B
| $1.43M | ﹤0.01% |
576,056
+511,752
| +796% | +$2.28M |
|
3644
CALL
Moderna
MRNA
$25.3B
| $1.43M | ﹤0.01% |
10,000
-190,000
| -95% | -$27.2M |
|
|
GIIX
3645
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
| $1.43M | ﹤0.01% |
144,939
-686,390
| -83% | -$6.79M |
|
3646
Eos Energy Enterprises
EOSE
$1.46B
| $1.43M | ﹤0.01% |
1,179,054
+554,198
| +89% | +$1.14M |
|
|
CMCT
3647
Creative Media & Community Trust
CMCT
$14M
| $1.42M | ﹤0.01% |
8
| – | – |
|
3648
Tennant Co
TNC
$1.17B
| $1.42M | ﹤0.01% |
23,974
+2,574
| +12% | +$166K |
|
3649
Camping World
CWH
$662M
| $1.42M | ﹤0.01% |
65,584
-49,950
| -43% | -$1.32M |
|
|
KALV
3650
DELISTED
KalVista Pharmaceuticals
KALV
| $1.42M | ﹤0.01% |
143,851
+130,427
| +972% | +$1.44M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.